Skip to main content

Table 1 Epidemiological and clinical characteristics of 81 HD patients

From: Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients

Age (years)

59.8 ± 15.7

Male

52 (64.2)

Dialysis duration (months)

66.2 ± 53.9

Diabetes mellitus

17 (21)

Hypertension

57 (70.4)

History of CVD

30 (37)

Smoking

25 (30.9)

Statins

29 (35.8)

Anti-hypertensives

57 (70,4)

Anti-HPTH treatment

46 (56.8)

ESA

73 (90,1)

Intravenous iron

73 (90,1)

BMI (kg/m2)

24.6 ± 4.1

SAP (mmHg)

136.1 ± 18.9

DAP (mmHg)

83.6 ± 12.1

PP (mmHg)

52.9 ± 13.8

MAP (mmHg)

100.9 ± 13.4

  1. Values are expressed as mean±SD or numbers (%) as appropriate.
  2. CVD cardiovascular disease, DAP diastolic arterial pressure, ESA erythropoiesis stimulating agent, HPTH hyperparathyroidism, MAP mean arterial pressure, PP pulse pressure, SAP systolic arterial pressure.
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us